These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 27484578)

  • 1. Diverse modes of NMDA receptor positive allosteric modulation: Mechanisms and consequences.
    Hackos DH; Hanson JE
    Neuropharmacology; 2017 Jan; 112(Pt A):34-45. PubMed ID: 27484578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimeric Glutamate Receptor Subunits Reveal the Transmembrane Domain Is Sufficient for NMDA Receptor Pore Properties but Some Positive Allosteric Modulators Require Additional Domains.
    Wilding TJ; Lopez MN; Huettner JE
    J Neurosci; 2016 Aug; 36(34):8815-25. PubMed ID: 27559165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function.
    Hackos DH; Lupardus PJ; Grand T; Chen Y; Wang TM; Reynen P; Gustafson A; Wallweber HJ; Volgraf M; Sellers BD; Schwarz JB; Paoletti P; Sheng M; Zhou Q; Hanson JE
    Neuron; 2016 Mar; 89(5):983-99. PubMed ID: 26875626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulating synaptic NMDA receptors.
    Tovar KR; Westbrook GL
    Neuropharmacology; 2017 Jan; 112(Pt A):29-33. PubMed ID: 27565459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher ambient synaptic glutamate at inhibitory versus excitatory neurons differentially impacts NMDA receptor activity.
    Yao L; Grand T; Hanson JE; Paoletti P; Zhou Q
    Nat Commun; 2018 Oct; 9(1):4000. PubMed ID: 30275542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism and properties of positive allosteric modulation of N-methyl-d-aspartate receptors by 6-alkyl 2-naphthoic acid derivatives.
    Sapkota K; Irvine MW; Fang G; Burnell ES; Bannister N; Volianskis A; Culley GR; Dravid SM; Collingridge GL; Jane DE; Monaghan DT
    Neuropharmacology; 2017 Oct; 125():64-79. PubMed ID: 28709671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The NMDA receptor intracellular C-terminal domains reciprocally interact with allosteric modulators.
    Sapkota K; Dore K; Tang K; Irvine M; Fang G; Burnell ES; Malinow R; Jane DE; Monaghan DT
    Biochem Pharmacol; 2019 Jan; 159():140-153. PubMed ID: 30503374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive Allosteric Modulation as a Potential Therapeutic Strategy in Anti-NMDA Receptor Encephalitis.
    Warikoo N; Brunwasser SJ; Benz A; Shu HJ; Paul SM; Lewis M; Doherty J; Quirk M; Piccio L; Zorumski CF; Day GS; Mennerick S
    J Neurosci; 2018 Mar; 38(13):3218-3229. PubMed ID: 29476014
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhancing NMDA Receptor Function: Recent Progress on Allosteric Modulators.
    Yao L; Zhou Q
    Neural Plast; 2017; 2017():2875904. PubMed ID: 28163934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel allosteric modulator binding sites in NMDA receptors: A molecular modeling study.
    Kane LT; Costa BM
    J Mol Graph Model; 2015 Sep; 61():204-13. PubMed ID: 26280688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMDAR PAMs: Multiple Chemotypes for Multiple Binding Sites.
    Goldsmith PJ
    Curr Top Med Chem; 2019; 19(24):2239-2253. PubMed ID: 31660834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allosteric modulators of NMDA receptors: multiple sites and mechanisms.
    Zhu S; Paoletti P
    Curr Opin Pharmacol; 2015 Feb; 20():14-23. PubMed ID: 25462287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMDA receptor subunits: function and pharmacology.
    Paoletti P; Neyton J
    Curr Opin Pharmacol; 2007 Feb; 7(1):39-47. PubMed ID: 17088105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular bases of NMDA receptor subtype-dependent properties.
    Glasgow NG; Siegler Retchless B; Johnson JW
    J Physiol; 2015 Jan; 593(1):83-95. PubMed ID: 25556790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive allosteric modulation of NMDA receptors: mechanisms, physiological impact and therapeutic potential.
    Geoffroy C; Paoletti P; Mony L
    J Physiol; 2022 Jan; 600(2):233-259. PubMed ID: 34339523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Bioactive Protein-Ligand Conformation of GluN2C-Selective Positive Allosteric Modulators Bound to the NMDA Receptor.
    Kaiser TM; Kell SA; Kusumoto H; Shaulsky G; Bhattacharya S; Epplin MP; Strong KL; Miller EJ; Cox BD; Menaldino DS; Liotta DC; Traynelis SF; Burger PB
    Mol Pharmacol; 2018 Feb; 93(2):141-156. PubMed ID: 29242355
    [No Abstract]   [Full Text] [Related]  

  • 17. Structural rearrangements of NR1/NR2A NMDA receptors during allosteric inhibition.
    Gielen M; Le Goff A; Stroebel D; Johnson JW; Neyton J; Paoletti P
    Neuron; 2008 Jan; 57(1):80-93. PubMed ID: 18184566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The N-terminal domains of both NR1 and NR2 subunits determine allosteric Zn2+ inhibition and glycine affinity of N-methyl-D-aspartate receptors.
    Madry C; Mesic I; Betz H; Laube B
    Mol Pharmacol; 2007 Dec; 72(6):1535-44. PubMed ID: 17878266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel NMDA receptor positive allosteric modulator that acts via the transmembrane domain.
    Wang TM; Brown BM; Deng L; Sellers BD; Lupardus PJ; Wallweber HJA; Gustafson A; Wong E; Volgraf M; Schwarz JB; Hackos DH; Hanson JE
    Neuropharmacology; 2017 Jul; 121():204-218. PubMed ID: 28457974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New advances in NMDA receptor pharmacology.
    Ogden KK; Traynelis SF
    Trends Pharmacol Sci; 2011 Dec; 32(12):726-33. PubMed ID: 21996280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.